Insider Transactions Reported by 19 Insiders of Avidity Biosciences, Inc.

Symbol
RNA on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

Avidity Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
RTW INVESTMENTS, LP 10%+ Owner $48,573,350 04 Aug 2021
Sarah Boyce President and CEO, Director $20,683,154 -$5,008,989 -19% 17 Dec 2025
LEVIN ARTHUR A Director $12,165,364 -$5,172,418 -30% 19 Dec 2025
Teresa McCarthy Chief Human Resources Officer $8,540,455 -$2,416,027 -22% 17 Dec 2025
W. Michael Flanagan Chief Scientific Officer $6,755,780 -$2,567,070 -28% 17 Dec 2025
Kathleen P. Gallagher Chief Program Officer $5,809,827 -$1,220,744 -17% 17 Dec 2025
Eric Mosbrooker Chief Commercial Officer $5,678,448 -$6,370,403 -53% 17 Dec 2025
John B. Moriarty Chief Legal Officer $5,529,030 -$81,291 -1.4% 17 Dec 2025
Charles Calderaro III Chief Technical Officer $3,846,769 17 Dec 2025
TROY E. WILSON Director $3,376,910 -$5,752,430 -63% 05 Sep 2025
Michael F. MacLean Chief Financial Officer $2,811,653 -$1,661,254 -37% 06 Aug 2025
Steven George Hughes Chief Medical Officer $1,847,713 -$4,329,665 -70% 22 Oct 2025
Tamar Thompson Director $196,276 10 Jun 2025
Simona Skerjanec Director $196,276 10 Jun 2025
Noreen Henig Director $196,276 10 Jun 2025
Jean Jinsun Kim Director $196,276 10 Jun 2025
Edward M. MD Kaye Director $196,276 10 Jun 2025
CARSTEN BOESS Director $196,276 10 Jun 2025
RODERICK WONG Director, 10%+ Owner 16 Jun 2021

Recent Insider Transactions by Companies or Individuals for Avidity Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.